Skip to main content
Caplight Logo









One-carbon Therapeutics AB

One-carbon Therapeutics AB

Private
SolnaHealthcare & Life Scienceshttps://one-carbon.com/

Last Round

Private Placement

Dec 1, 2025

Total Funding Raised

$1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

One-carbon Therapeutics AB is a biotechnology company that develops novel anti-cancer therapies targeting the one-carbon metabolic pathway.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyoncologydrug discoverysmall-molecule inhibitorclinical trialsprecision medicinecancer therapymetabolic pathwaysolid tumorsbiotech startupdrug developmentsynthetic lethalitycomputational chemistryclinical-stage biotechpharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

One-carbon Therapeutics AB Comparables

Compare One-carbon Therapeutics AB with similar companies based on industry and business-model similarity.

One-carbon Therapeutics AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImmunoMet Therapeutics
78%
Daiichi Sankyo
71%
Tango Therapeutics
69%

One-carbon Therapeutics AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementDec 1, 2025
SeedOct 22, 2021

Key People

Founding team and executive leadership

Ana Slipicevic

Chief Executive Officer

Executive Team

One-carbon Therapeutics AB Investors

Notable investors and investment history

One-carbon Therapeutics AB investors
InvestorRounds
Eir VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 445% MoM, reaching 1.8K.

  • Apr 6, 2026

    Monthly visitors increased 134% MoM.

One-carbon Therapeutics AB Filings

Explore SEC and related filing metadata, where available.

One-carbon Therapeutics AB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about One-carbon Therapeutics AB's valuation, stock price, and market status.

Is One-carbon Therapeutics AB a public or private company?

One-carbon Therapeutics AB is a private company.

What is the current stock price of One-carbon Therapeutics AB?

One-carbon Therapeutics AB is a private company with no public stock price. Caplight tracks One-carbon Therapeutics AB's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is One-carbon Therapeutics AB worth (valuation)?

Valuation information for One-carbon Therapeutics AB is not publicly available.

Can I buy One-carbon Therapeutics AB stock?

One-carbon Therapeutics AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was One-carbon Therapeutics AB's last funding round?

One-carbon Therapeutics AB's most recent funding round was Private Placement on December 1, 2025.

Who are the main investors in One-carbon Therapeutics AB?

Key investors in One-carbon Therapeutics AB include Eir Ventures.

Will One-carbon Therapeutics AB IPO soon?

No public IPO plans have been announced for One-carbon Therapeutics AB.

How can I track One-carbon Therapeutics AB secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor One-carbon Therapeutics AB's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSolna
Employee Range4
Year Founded2020
Last FundingDec 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?